Related Experiment Video
Updated: Aug 10, 2026

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
Relationship between plasma total antioxidant capacity and thoracic aortic intima-media thickness
Recep Demirbag1, Remzi Yilmaz, A Sami Kunt
1Department of Cardiology, Faculty of Medicine, Harran University, Sanliurfa, Turkey. rdemirbag@yahoo.com
Insights
Total antioxidant capacity (TAC) is linked to a lower risk of thoracic aortic atherosclerosis. Lower TAC levels correlate with increased thoracic aortic intima-media thickness (TAIMT) and atherosclerosis severity.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
- Medical Imaging
Background:
- Antioxidants play a crucial role in preventing coronary artery disease (CAD).
- Low total antioxidant capacity (TAC) is a known risk factor for ischemic heart disease.
- Limited data exist on the relationship between TAC and thoracic aortic atherosclerosis severity.
Purpose of the Study:
- To investigate the association between total antioxidant capacity (TAC) and atherosclerotic thoracic aortic intima-media thickness (TAIMT).
- To determine if TAC is an independent predictor of thoracic aortic atherosclerosis.
Main Methods:
- Utilized multiplane transesophageal echocardiography (TEE) to assess TAIMT and the grade of thoracic aortic atherosclerosis.
- Measured TAC in 29 patients without a history of cardiovascular disease, excluding those with obesity, hypertension, diabetes, or CAD.
- Employed a recently developed method for TAC measurement.
Main Results:
- A significant negative correlation was observed between TAC levels and both TAIMT (r = -0.799) and the grade of thoracic aortic atherosclerosis (r = -0.827).
- Multiple linear regression confirmed TAC as an independent predictor of TAIMT (beta = -0.734).
- TAC levels progressively decreased with increasing grades of thoracic aortic atherosclerosis (Grade I: 2.23 ± 0.31; Grade II: 1.58 ± 0.31; Grade III: 1.04 ± 0.27 mmol Trolox equiv/l; ANOVA P < 0.001).
Conclusions:
- Total antioxidant capacity (TAC) is an independent variable associated with thoracic aortic intima-media thickness (TAIMT).
- TAC may serve as an independent predictor for atherosclerotic lesions in major arteries.
- Findings suggest TAC's potential role in assessing the risk and severity of aortic atherosclerosis.
Abstract:
It is known that antioxidants have an important role in the prevention of coronary artery disease (CAD). Low total antioxidant capacity (TAC) is a risk factor for ischemic heart disease. However, no data are available concerning the relationship between TAC and severity of thoracic aortic atherosclerosis. This study using multiplane transesophageal echocardiography (TEE) examined the relationship between atherosclerotic thoracic aortic intima-media thickness (TAIMT) and TAC. Twenty-nine patients (17 male, 12 female; mean age 36 +/- 8 years) without a history of atherosclerotic cardiovascular disease referred for TEE were included. The patients with obesity, hypertension, diabetes, and CAD were excluded. The TAC was measured for each patient using a more recently developed method. TAIMT and grade of thoracic aortic atherosclerosis were evaluated in each patient by using TEE. Mean TAC level was 1.91 +/- 0.53 mmol Trolox equiv/l. There was a negative and significant correlation between the TAC levels and TAIMT and grade of thoracic aortic atherosclerosis (r = -0.799, P < 0.001 versus r = -0.827, P < 0.001, respectively). Multiple linear regression analysis showed that TAIMT was independently associated with TAC (beta = -0.734, P < 0.001). The mean values of TAC in grade I, II, and III were 2.23 +/- 0.31, 1.58 +/- 0.31, and 1.04 +/- 0.27 mmol Trolox equiv/l, respectively (ANOVA P < 0.001). This study indicates that the TAC is an independent variable for TAIMT and it has a potential for an independent variable for atherosclerotic lesions in the major arterial locations.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Thoracic Aorta
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Aneurysm II: Clinical Manifestations and Diagnostic Studies
